OUR MISSION
Accelerate the management and treatment of chronic disease at a community care setting resulting in fewer hospitals days.
OUR STORY
During the Covid-19 Pandemic, we witnessed firsthand the impact of reduced hospital access, especially on ‘Elderly’ chronic patients. Simple routine tasks such as Diabetic foot ulcer assessment and wound dressing change could not be performed, leaving many patients in a distressful situation. It also made us realize how ill-equipped the family caregivers and Primary care HCPs were to manage these routine diseases management tasks. Based upon this need, Longlive was born.
We established Longlive in June 2021. We have developed a prototype for our solution. The next step for us is to conduct 500 patient studies to validate and refine our solution before launching in the hands of those who need it the most.
Longlive is registered and based in London and is part of the Health Foundry London ecosystem, whilst our ambition is truly global!
Target
£100,000
Raised
£1,000
Minimum
£10,000
- Potential Market size 2 billion users
- Year 5 revenue forecast € 480 mln with ten mln user base
- No Debt in the Company
- Health-Focused smartwatch captures ten continuous health data points
- Due to sizeable users data since the end of year 3, Longlive will become Prime acquisition target
Join now. It's free, quick and easy.
Join our community to view the full investment opportunity.
Already have an account?
Investing in a startup involves risk, including loss of capital, lack of liquidity and dividends, and dilution, and should be done only as a part of a diversified portfolio. Please read our Capital at Risk Warning before investing. Please note that investments should be made by investors who understand and accept these risks, and tax treatment depends on individual circumstances and is subject to change at any time.
TrendScout does not provide legal, financial, tax or investment recommendations, and no communications from TrendScout, through this website or any other medium should be construed as such. Furthermore, nothing on this website shall be considered as an offer to sell or a solicitation of an offer to buy any equity, shares, or security to any person in any jurisdiction to whom or in which such offer, solicitation or sale is illegal.
